Bluebird Bio

What Bluebird Bio Gets Wrong In Pricing For Its $1.8 Million Drug
Forbes
Wed, 06/19/19 - 09:55 am
Bluebird Bio
gene therapy
drug pricing
Zynteglo
beta thalassemia
Bluebird delays gene therapy launch to 2020, citing manufacturing tweaks
Biopharma Dive
Tue, 06/18/19 - 11:57 am
Bluebird Bio
gene therapy
drug manufacturing
Zynteglo
bluebird offers installment payments for Zynteglo gene therapy
Pharmaforum
Mon, 06/17/19 - 12:25 pm
Bluebird Bio
outcome-based pricing
drug pricing
gene therapy
Zynteglo
beta thalassemia
Is $1.8 Million for bluebird bio's New Gene Therapy Ridiculous?
Motley Fool
Sat, 06/15/19 - 05:49 pm
Bluebird Bio
Zynteglo
drug pricing
beta thalassemia
Bluebird sets $1.8M price tag for blood-disease gene therapy
Biopharma Dive
Fri, 06/14/19 - 12:08 pm
drug pricing
Bluebird Bio
Zynteglo
Europe
beta thalassemia
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts
Yahoo/Benzinga
Sun, 06/9/19 - 01:36 pm
ADA
Merck
Keytruda
NGM Biopharmaceuticals
NGM313/MK-3655
Corbus Pharmaceuticals
Nektar
Galapagos
Kezar Life Sciences
Kura Oncology
Bluebird Bio
BeiGene
Global Blood Therapeutics
Blueprint Medicines
Regeneron
Arqule
Sunesis
Sutro BioPharma
Incyte
Geron
Forty Seven
Patients, payers await pricing plans for bluebird's first approved gene therapy
BioCentury
Tue, 06/4/19 - 11:04 am
Bluebird Bio
gene therapy
Zynteglo
drug pricing
beta thalassemia
Bluebird Bio’s Gene Therapy for Blood Disease Wins European Approval
Xconomy
Mon, 06/3/19 - 07:50 pm
Bluebird Bio
gene therapy
Europe
Zynteglo
EMA
beta thalassemia
Top 5 New Drug Launches of 2019 -- and the Biotech Stocks That Could Win Big
Motley Fool
Sun, 05/19/19 - 04:05 pm
Alexion
Ultomiris
AbbVie
Upadacitinib
risankizumab
Aimmune Therapeutics
AR-101
Bluebird Bio
LentiGlobin
Bluebird's not looking to break speed records with its first gene therapy launch
Fierce Pharma
Fri, 05/10/19 - 12:48 pm
Bluebird Bio
gene therapy
beta thalassemia
Zynteglo
drug launches
bluebird to rollout Zynteglo starting in Germany next half
BioCentury
Thu, 05/9/19 - 11:09 pm
Bluebird Bio
beta thalassemia
Germany
Zynteglo
bluebird bio Flies Forward
Motley Fool
Wed, 05/8/19 - 10:12 am
Bluebird Bio
earnings
Celgene reports 'durable' responses to multiple myeloma CAR-T in early trial despite relapses
Fierce Biotech
Fri, 05/3/19 - 10:45 am
Celgene
Bluebird Bio
bb2121
cell therapy
CAR-T
Multiple Myeloma
Sanofi leases its soon-to-be-former Genzyme HQ to Bluebird Bio—at a profit
Fierce Pharma
Tue, 04/23/19 - 11:05 pm
Sanofi
Bluebird Bio
Kendall Square
Boston
Here's Why Shares of bluebird bio Slumped Today
Motley Fool
Wed, 04/17/19 - 10:36 pm
Bluebird Bio
2 Blockbuster Gene Therapy Programs to Watch in 2019
Motley Fool
Sun, 03/31/19 - 03:42 pm
gene therapy
Zolgensma
Novartis
Bluebird Bio
LentiGlobin
First gene therapy to treat rare blood disease nears European approval
Stat
Fri, 03/29/19 - 10:05 am
Bluebird Bio
Europe
LentiGlobin
gene therapy
beta-thalassemia
Bluebird opens manufacturing facility as it moves gene therapies forward
Fierce Pharma
Tue, 03/26/19 - 11:39 am
Bluebird Bio
gene therapy
cell therapy
drug manufacturing
bluebird bio to Cut Ribbon on New Gene Therapy Factory in Durham, NC; Plans to Hire
BioSpace
Fri, 03/22/19 - 10:06 pm
Bluebird Bio
gene therapy
drug manufacturing
bb2121
bb21217
LentiGlobin
Here's Why bluebird bio Gained 16.3% in February
Motley Fool
Mon, 03/11/19 - 09:50 am
Bluebird Bio

Pages